Scholarly Index
Pamela N. Münster
University of California, San Francisco; 19,389 total citations; 424 total publications; best world rank #103
University of California, San Francisco
19,389Total citations
424Total publications
66H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Histone Deacetylase Inhibitors Research | Lifetime | 103 | US 71 | 98.85 |
| Cancer Treatment and Pharmacology | Lifetime | 477 | US 244 | 98.65 |
| Protein Degradation and Inhibitors | Lifetime | 227 | US 137 | 98.18 |
| Advanced Breast Cancer Therapies | Lifetime | 235 | US 111 | 98.05 |
| HER2/EGFR in Cancer Research | Lifetime | 494 | US 228 | 97.96 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 503 | US 281 | 96.29 |
| PARP inhibition in cancer therapy | Lifetime | 461 | US 218 | 94.89 |
| Cancer Treatment and Pharmacology | 2021-2025 | 425 | US 153 | 91.71 |
| PARP inhibition in cancer therapy | 2021-2025 | 313 | US 118 | 90.85 |
| Advanced Breast Cancer Therapies | 2021-2025 | 465 | US 165 | 91.33 |
| DNA Repair Mechanisms | 2021-2025 | 387 | US 169 | 87.47 |
| Estrogen and related hormone effects | 2021-2025 | 509 | US 170 | 79.24 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 382 | US 133 | 74.30 |